NIOX Group (LON:NIOX) Shares Up 0.6% - Here's What Happened

Key Points

• NIOX Group's shares rose 0.6% during mid-day trading, with last traded prices at GBX 71.40 ($0.95), although the trading volume was down 32% compared to its average.
• Wall Street analysts maintain a "buy" rating on NIOX, with a price target of GBX 90 ($1.20) from Deutsche Bank and Berenberg Bank.
• Insider Jonathan Emms sold over 2.7 million shares of the company at an average price of GBX 65 ($0.86), indicating significant insider movement in the stock.

NIOX Group Plc (LON:NIOX - Get Free Report) rose 0.6% on Tuesday . The company traded as high as GBX 71.60 ($0.96) and last traded at GBX 71.40 ($0.96). Approximately 752,352 shares changed hands during trading, a decline of 32% from the average daily volume of 1,112,394 shares. The stock had previously closed at GBX 71 ($0.95).

Analyst Upgrades and Downgrades

NIOX has been the topic of a number of recent analyst reports. Berenberg Bank restated a "buy" rating and set a GBX 90 ($1.21) price objective on shares of NIOX Group in a research note on Tuesday, April 15th. Deutsche Bank Aktiengesellschaft restated a "buy" rating and set a GBX 90 ($1.21) price objective on shares of NIOX Group in a research note on Tuesday, April 15th.

NIOX Group Trading Up 1.1%

The business has a fifty day moving average of GBX 68.54 and a 200-day moving average of GBX 65.91. The stock has a market capitalization of £29.24 billion, a price-to-earnings ratio of 2,938.30 and a beta of 0.92. The company has a debt-to-equity ratio of 1.10, a current ratio of 6.31 and a quick ratio of 1.94.

Insider Transactions at NIOX Group

In related news, insider Jonathan Emms sold 2,745,925 shares of NIOX Group stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of GBX 65 ($0.87), for a total value of £1,784,851.25 ($2,400,606.93). Also, insider Ian Johnson sold 3,924,630 shares of NIOX Group stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of GBX 65 ($0.87), for a total value of £2,551,009.50 ($3,431,082.04). 46.72% of the stock is owned by insiders.

NIOX Group Company Profile

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients.